KIF14 and medulloblastoma: KIF14 was identified as a candidate oncogene in the 1q minimal region of genomic gain in breast cancer, medulloblastoma, lung cancer, retinoblastoma, and renal cell carcinomas 39 with its overexpression being associated with poorer prognosis in these malignancies.